Seladelpar Effect on Lipids and Muscle Safety With Concomitant Statin Use in Patients With Primary Biliary Cholangitis: Interim Results From the Open-Label ASSURE Study With up to 4 Years of Treatment

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Seladelpar Effect on Lipids and Muscle Safety With Concomitant Statin Use in Patients With Primary Biliary Cholangitis: Interim Results From the Open-Label ASSURE Study With up to 4 Years of Treatment

	EASL 2026 May 26-30 Barcelona Christopher L. Bowlus1,